Substituted pyrazole compounds

Details Substituted pyrazole compounds Substituted pyrazole compounds

2004-03-10

2010-11-30

Wilson, James O (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C514S277000, C544S364000, C546S001000

Reexamination Certificate

active

07842695

ABSTRACT:
Compounds of formula (I) and salts thereof, in which the following definitions apply: X is N or CH; R1is H, A, Hal, (CH2)nHet, (CH2)nAr, C3-7-cycloalkyl, CF3, NO2, CN, C(NH)(OH), or OCF3; R2is (CH2)nHet, (CH2)nAr, or C3-7-cycloalkyl, or CF3; R3and R4denote H or an organic radical. Compounds of formula (I) are useful as ligands of 5-HT receptors and useful in the treatment of disorders such as anxiety, depression, obsessive-compulsive disorder and pain.

REFERENCES:
patent: 3926999 (1975-12-01), Poetsch
patent: 4146721 (1979-03-01), Rainer
patent: 4258047 (1981-03-01), Gante et al.
patent: 4631343 (1986-12-01), Beck
patent: 6043261 (2000-03-01), Hansen, Jr. et al.
patent: 6090807 (2000-07-01), Hellendahl et al.
patent: 6159393 (2000-12-01), Poetsch et al.
patent: 7067507 (2006-06-01), Pulley et al.
patent: 7368578 (2008-05-01), Momose et al.
patent: 2001/0044445 (2001-11-01), Bamaung et al.
patent: 2002/0091116 (2002-07-01), Zhu et al.
patent: 2004/0034083 (2004-02-01), Stephenson et al.
patent: 2006/0264419 (2006-11-01), Schiemann et al.
patent: 2006/0276650 (2006-12-01), Schadt et al.
patent: 2007/0093492 (2007-04-01), Jiaang et al.
patent: 2007/0105871 (2007-05-01), Schiemann et al.
patent: 21 41 125 (1972-02-01), None
patent: 2201889 (1973-07-01), None
patent: 2258033 (1974-05-01), None
patent: 2906252 (1980-08-01), None
patent: WO 96/33175 (1996-10-01), None
patent: WO 98031227 (1998-07-01), None
patent: WO 01/29008 (2001-04-01), None
patent: WO 0132626 (2001-05-01), None
patent: WO0132627 (2001-10-01), None
patent: WO 03/031435 (2003-04-01), None
patent: WO 03031345 (2003-04-01), None
patent: WO 03031435 (2003-04-01), None
patent: WO 03088958 (2003-10-01), None
patent: WO 03/099793 (2003-12-01), None
patent: WO 2004/024705 (2004-03-01), None
patent: WO 2004/037248 (2004-05-01), None
Vippagunta et al. Advanced Drug Delivery Reviews, 2001, 48, 3-26.
“Premenstrual syndrome-Womens health and Medical Information in Medicinenet.com”, http://www.medicinenet.com/premenstrual—syndrome/page5.htm, accessed Sep. 19, 2007.
“Amyotrophic Lateral sclerosis information page: National Institute of Neurological Disorders and Stroke (NINDS)”, http://www.ninds.gov/disorders/amyotrophiclateralsclerosis/amyotrophiclateralsclerosis.htm, accessed Sep. 19, 2007.
“Obsessive-compulsvie behaviors and disorders: symptoms, treatment, and support”, http://www.helpguide.org/mental/obsessive—compulsive—disorder—ocd.htm, accessed Sep. 19, 2007.
Journal of Clinical Psychiatry, 1999, 60, 1-8.
Crow, S. Expert Opinion on Investigational Drugs, 1997, 6(4), 427-36.
Wood et al. Expert Opinion in Investigational Drugs, 2002, 11(4), 457-67.
Crow, Expert Opinion in Investigational Drugs, 1997, 6(4), 427-36.
Thompson et al. Expert Opinion on Therapeutic Targets, 2007, 11(4), 527-40.
Roth et al. Expert Opinion on Therapeutic Targets, 2001, 5(6), 685-95.
Slassi et al. Expert Opinion on Therapeutic Patents, 2002, 12(4), 513-27.
Bishop et al. Expert Opnion on Therapeutic Patents, 2003, 13(11), 1691-1705.
Ross et al. Expert Opinion On Therapeutic Patents, 2003, 13(10), 1491-99.
Database Beilstein Online—Beilstein Institute for Organic Chemistry, Frankfurt-Main, DE; Jun. 27, 1988, XP002283830.
Vippagunta et al. Advanced Drug Delivery Reviews, 2001, 48, 3-26.
Takehito Ochi et al.: “FR143166 Attenuates Spinal Pain Transmission Through Activation of the Serotonig System” European Journal of Pharmacology, Bd. 452, 2002, pp. 319-324, XP002284473, The Entire Document.
Yoshiko Suzuki et al: “in vitro and in vivo Pharmacological Profile of 4-(4-Fluorobenzylidene)-1-{2-′5-(4-Fluorop Henyl)-1H-Pyrazol-4-Yliethyl} Piperidine (NRA0161)” Life Sciences, Bd. 71, 2002, pp. 2603-2615, XP002284474, The Entire Document.
Katritzky et al: “1,3-Dipolar Cycloadditions of Electron-Rich Benzotriazol-1-Ylpropenes” J. Heterocyclic Chem., Bd. 33, 1996, pp. 1637-1646, XP002284475, Figure 28, pp. 1640.
O'Brian et al: “Some Reactions of 3-Hydroxy-1-Phenylpyrazole” J. Org. Chem., Bd.31, 1966, pp. 1538-1542, XP002284477, The Entire Document.
Database CHEMABS ′Online! Chemical Abstracts Service, Columbus, Ohio, US; 1960, Grandberg, I.I. et al: “Pyrazoles” XP002284480, Found in STN, Database Accession No. 1961:99421, Summary & Zhurnal Obshchei Khimii, 30, 3324-8; CODEN: ZOKHA4; ISSN: 0044-460X, 1960.
Database Beilstein; Beilstein Institute for Organic Chemistry, Frankfurt-Main, DE; Nov. 29, 1988; XP002284481, Database Accession No. BRN 1127514 CAS-RN; 35000-58-9/ Summary & Dorn et al: J. Prakt. Chem., Bd. 313, 1971, pp. 236-246.
Bebernitz et al.: “The Effect of 1,3-Diaryl-'1H!-Pyrazol-4-Acetamides on Glucose Utilization in OB/OB Mice” J. Med. Chem., Bd. 44, Nr. 16, 2001, pp. 2601-2611, XP002284478; Schema 1, Methode A, Strukturen 2-5, Reaktionen A and B.
Echevarria et al: Research in the Azole Series. 102 ′1?. Synthesis and 13C NMR Study of Pyrazole-4-Carboxaldehydes: J. Heterocyclic Chem., Bd. 30, 1993, pp. 957-960, XP002284479, Formula 19, p. 957.
Carmella, et al., Heterocycles, vol. 40, No. 2, 1995, pp. 515-520.
Non-Final Rejection dated Aug. 25, 2008—U.S. Appl. No. 10/552,065 filed Oct. 5, 2005 (Publication No. 2006/0264419 A1).
Non-Final Rejection dated Nov. 20, 2007—U.S. Appl. No. 10/551,998 filed Oct. 5, 2006 (Publication No. 2007/0105871 A1).
Final Rejection dated Aug. 7, 2008—U.S. Appl. No. 10/551,998 filed Oct. 5, 2006 (Publication No. 2007/0105871 A1).
Non-Final Rejection dated Jan. 22, 2008—U.S. Appl. No. 10/551,905 filed Oct. 5, 2005 (Publication No. 2006/0276650 A1).
Final Rejection dated Aug. 8, 2008—U.S. Appl. No. 10/551,905 filed Oct. 5, 2005 (Publication No. 2006/0276650 A1).
Non-Final Rejection dated Mar. 12, 2009—U.S. Appl. No. 10/551,905 filed Oct. 5, 2005 (Publication No. 2006/0276650 A1).
Russian Journal of Organic Chemistry, vol. 37, No. 4, 2001, pp. 552-555 “4-Functionally Substituted 3-Heterylpyrazoles: III. 3-Aryl(heteryl)pyrazole-4-carboxylic Acids and Their Derivatives”, M. K. Bratenko et al.

Affiliated with

Also associated with

Rating

Substituted pyrazole compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Substituted pyrazole compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted pyrazole compounds will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4150282